Drug Shortage Report for ABRAXANE FOR INJECTABLE SUSPENSION

Last updated on 2021-10-02 History
Report ID 144114
Drug Identification Number 02281066
Brand name ABRAXANE FOR INJECTABLE SUSPENSION
Common or Proper name paclitaxel
Company Name CELGENE INC
Market Status MARKETED
Active Ingredient(s) PACLITAXEL
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Vial
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-01
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-10-02
Company comments Allocation will be based on historical demand.
Health Canada comments
Contact Address 2344 ALFRED-NOBEL BOULEVARD
SAINT-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2021-10-02 French Compare
v12 2021-09-28 French Compare
v11 2021-09-28 English Compare
v10 2021-09-28 French Compare
v9 2021-09-28 English Compare
v8 2021-09-24 French Compare
v7 2021-09-24 English Compare
v6 2021-09-23 French Compare
v5 2021-09-23 English Compare
v4 2021-08-13 French Compare
v3 2021-08-13 English Compare
v2 2021-08-13 French Compare
v1 2021-08-13 English Compare